AI-generated summary
The authors studied photobiomodulation (810 nm diode laser) in 30 male Wistar rats with surgically created 8-mm skull defects, measuring bone healing, inflammatory and angiogenic markers over several follow-up periods. They report that IL-1 decreased and PTGIR improved at 7 days, and VEGF expression rose at 3 days, while changes in OCN and ALP were not statistically significant. The study was conducted in rats and its authors describe the results as applying under their specific conditions.
- Participants
- 30
- Who or what was studied
- 30 male Wistar rats with 8-mm critical-sized calvarial defects
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The study was in rats, the abstract reports non-significant changes for some markers, and the results apply only under the study's specific conditions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 4 J/cm2
- Power density (irradiance)
- 100 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Control group, Angiogenesis, Inflammation, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.